Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Numinus Wellness Focused on Boosting Profitability and Expanding Community Support (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Cronos Group Inc CRON


Primary Symbol: T.CRON

Healthcare Cannabis
Cronos Group Inc. is a Canada-based global cannabinoid company engaged in building intellectual property by advancing cannabis research, technology and product development. The Company’s segments include United States and Rest of World. The United States operating segment consists of the manufacture and distribution of hemp-derived CBD infused products. The Rest of World operating segment is... see more

Recent & Breaking News (TSX:CRON)

ONGOING INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Cronos Group Inc. and Encourages Investors with Losses to Contact the Firm

PR Newswire November 23, 2021

Cronos Group Provides Bi-Weekly MCTO Status Update and Announces Receipt of Nasdaq Listing Delinquency Letter

GlobeNewswire November 19, 2021

CRONOS ALERT: Bragar Eagel & Squire, P.C. is Investigating Cronos Group Inc. on Behalf of Cronos Stockholders and Encourages Investors to Contact the Firm

Business Wire November 17, 2021

CRON INVESTIGATION: Hagens Berman, National Trial Attorneys, Encourages Cronos Group Inc. (CRON) Investors to Contact Firm's Attorneys, Firm Investigating Cronos' Admitted Improper Accounting

Newsfile November 16, 2021

INVESTIGATION NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Cronos Group Inc. and Encourages Investors with Losses to Contact the Firm

Newsfile November 15, 2021

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors Cronos Group Inc. - CRON

PR Newswire November 15, 2021

CRONOS ALERT: Bragar Eagel & Squire, P.C. is Investigating Cronos Group Inc. on Behalf of Cronos Stockholders and Encourages Investors to Contact the Firm

Business Wire November 12, 2021

INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Cronos Group Inc. and Encourages Investors with Losses to Contact the Firm

Business Wire November 12, 2021

CRON INVESTOR ALERT: ROSEN, A TOP RANKED LAW FIRM, Encourages Cronos Group Inc. Investors with Losses to Inquire About Class Action Investigation - CRON

Business Wire November 11, 2021

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Cronos Group Inc. (CRON) Investors to Contact Firm's Attorneys, Firm Investigating Cronos' Admitted Improper Accounting

PR Newswire November 10, 2021

Cronos Group Files Form 12b-25

John Ballem  November 10, 2021

Lost Money in Cronos Group, Inc?

Business Wire November 9, 2021

EQUITY ALERT: Levi & Korsinsky, LLP Reminds Investors of an Investigation Involving Possible Securities Fraud Violations by Certain Officers and Directors of Cronos Group Inc.

Newsfile November 9, 2021

SHAREHOLDER ALERT: Investigation of Cronos Group Inc. Announced by Holzer & Holzer, LLC

Newsfile November 9, 2021

Cronos Group Files Form 12b-25

GlobeNewswire November 9, 2021

Cronos Group Chief Innovation Officer Dr. Todd Abraham to Retire

GlobeNewswire October 29, 2021

Cronos Group Launches its First Cultured Cannabinoid Product, SPINACH FEELZ(TM) Chill Bliss 2:1 THC|CBG Gummy

GlobeNewswire October 20, 2021

Cronos Group (TSX:CRON) and Gingko Biworks reach equity milestone for CBG Acid

Jocelyn Aspa August 23, 2021

Cronos Group and Ginkgo Bioworks Announce Achievement of Equity Milestone in Partnership to Produce Cultured Cannabinoids

GlobeNewswire August 23, 2021

Cronos Group Inc. to Speak at the Canaccord Genuity 41st Annual Growth Conference

GlobeNewswire August 9, 2021